# EDGAR Filing Document

**Accession Number:** 0001658678
**File Stem:** 0001193125-25-253609
**Filing Date:** 2025-10
**Character Count:** 2894
**Document Hash:** 8db596c38412d15bfc041a78d5c89f08
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-253609.hdr.sgml**: 20251028

**ACCESSION NUMBER**: 0001193125-25-253609

**CONFORMED SUBMISSION TYPE**: RW

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251028

**DATE AS OF CHANGE**: 20251028

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BIOSTEM TECHNOLOGIES
- **CENTRAL INDEX KEY:** 0001658678
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 270400416
- **STATE OF INCORPORATION:** FL
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** RW

**SEC ACT:**
- **SEC FILE NUMBER:** 001-42292
- **FILM NUMBER:** 251425271

**BUSINESS ADDRESS:**
- **STREET 1:** 2836 CENTER PORT CIRCLE
- **CITY:** POMPANO BEACH
- **STATE:** FL
- **ZIP:** 33604
- **BUSINESS PHONE:** 954-380-8342

**MAIL ADDRESS:**
- **STREET 1:** 2836 CENTER PORT CIRCLE
- **CITY:** POMPANO BEACH
- **STATE:** FL
- **ZIP:** 33604

**BIOSTEM TECHNOLOGIES, INC.** 

**2836 Center Port Circle** 

**Pompano Beach, FL 33064** 

October 28, 2025

**VIA EDGAR** 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street NE

Washington, D.C. 20549-3561

---

| | |
|:---|:---|
| Attention: | Eric Atallah |
|  | Angela Connell |
|  | Laura Crotty |
|  | Tamika Sheppard |
|  | Suzanne Hayes |

---

---

| | |
|:---|:---|
| **Re:** | **Biostem Technologies**  |

---

**Application for Withdrawal of Registration Statement on Form 10-12(b)** 

**Initially filed September 27, 2024** 

**File No. 001-42292** 

Ladies and Gentlemen:

Pursuant to Rule 477 under the Securities Act of 1933, as amended, BioStem Technologies, Inc., a Florida corporation (the "**Company**"), hereby requests withdrawal of the Company's Registration Statement on Form 10, initially filed with the Commission on September 27, 2024, together with all exhibits and amendments thereto (the "**Registration Statement**"). The Company is in the process of revising its registration statement and accompanying financial statements to adequately address certain comments received from the Commission. No securities were sold in connection with the Registration Statement.

It is our understanding that this application for withdrawal of the Registration Statement will be deemed granted as of the date that it is filed with the Commission unless, within fifteen days after such date, the Company receives notice from the Commission that this application will not be granted.

If you have any questions or comments with respect to this matter, please call counsel for the Company, Flora Perez, at (954) 768-8210.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| BioStem Technologies, Inc. | BioStem Technologies, Inc. |
| By: | */s/ Jason Matuszewski* |
|  | Name: Jason Matuszewski |
|  | Title: Chairman and Chief Executive Officer |

---